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ABSTRACT
A total of 34 lactic acid bacteria isolates from 4 dif-
ferent Brazilian kefir grains were identified and charac-
terized among a group of 150 isolates, using the ability 
to tolerate acidic pH and resistance to bile salts as 
restrictive criteria for probiotic potential. All isolates 
were identified by amplified ribosomal DNA restriction 
analysis and 16S rDNA sequencing of representative 
amplicons. Eighteen isolates belonged to the species 
Leuconostoc mesenteroides, 11 to Lactococcus lactis 
(of which 8 belonged to subspecies cremoris and 3 to 
subspecies lactis), and 5 to Lactobacillus paracasei. To 
exclude replicates, a molecular typing analysis was per-
formed by combining repetitive extragenic palindromic-
PCR and random amplification of polymorphic DNA 
techniques. Considering a threshold of 90% similarity, 
32 different strains were considered. All strains showed 
some antagonistic activity against 4 model food patho-
gens. In addition, 3 Lc. lactis strains and 1 Lb. paracasei 
produced bacteriocin-like inhibitory substances against 
at least 2 indicator organisms. Moreover, 1 Lc. lactis 
and 2 Lb. paracasei presented good total antioxidative 
activity. None of these strains showed undesirable enzy-
matic or hemolytic activities, while proving susceptible 
or intrinsically resistant to a series of clinically relevant 
antibiotics. The Lb. paracasei strain MRS59 showed a 
level of adhesion to human Caco-2 epithelial cells com-
parable with that observed for Lactobacillus rhamnosus 
GG. Taken together, these properties allow the MRS59 
strain to be considered a promising probiotic candidate.
Key words:  kefir grain, lactic acid bacteria, lactoba-
cilli, probiotic property
INTRODUCTION
Kefir is a fermented milk product originating from 
the Northern Caucasus. The name kefir is derived 
from the Turkish language word keyif, meaning “good 
feeling” for the feelings experienced after drinking it 
(Leite et al., 2013b). The fermented beverage is acidic, 
viscous, and slightly carbonated, and it contains small 
amounts of alcohol (Leite et al., 2013a). Traditionally, 
kefir is made by using kefir grains as a starter (Leite 
et al., 2013a,b). Kefir grains are white to yellowish, 
cauliflower-like grains, 0.3 to 3.5 cm in diameter, with 
a slimy but firm texture. The grains are composed of an 
inert matrix made up of polysaccharides and proteins. 
The matrix is densely populated by lactic acid bacteria 
(LAB) species, acetic acid bacteria, and yeasts (Leite 
et al., 2012, 2013b).
Kefir beverage has a long tradition of consumption 
in Eastern Europe, and it is now spreading around the 
world due to its potential health-associated properties. 
Although some of the reported health benefits do not 
yet have well-documented scientific evidence or clinical 
demonstration, several in vitro and animal studies have 
associated kefir beverage with alleviation of lactose in-
tolerance (Hertzler and Clancy, 2003), immunomodula-
tion (Hong et al., 2009), antimicrobial activity against 
pathogenic microorganisms (Chifiriuc et al., 2011), and 
balance of the intestinal microbiota (Urdaneta et al., 
2007). Traditionally, the functional properties of kefir 
have been attributed mainly to its bioactive peptide 
content and to kefiran, its main soluble exopolysac-
charide (Santos et al., 2003; Rodrigues et al., 2005). 
However, the potential beneficial effects might also be 
mediated by the undefined microbial composition of 
this fermented milk or by the secondary metabolites 
(Nielsen et al., 2014).
Although a reasonable number of well-characterized 
probiotic strains are commercially available around 
the world, screening for novel strains is still of great 
interest from an industrial point of view (Vinderola et 
al., 2008; Ayeni et al., 2011). Additionally, strains ex-
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pressing unique and particular characteristics that may 
enable health benefits may arise in the characterization 
of natural fermented dairy products such as kefir. This 
traditional product might be an interesting source of 
LAB strain with specific functional properties. Even 
though many authors advocate the importance of hu-
man origin as a selective criterion for the search of 
probiotic strains, an expert panel proposed by FAO/
WHO (2006) suggested that the probiotic activity is 
more important than the source of the microorganism. 
In fact, previous reports described the evaluation and 
selection of kefir LAB isolates for potential use as pro-
biotics (Golowczyc et al., 2008; Zheng et al., 2013).
The aim of the present study was to identify and 
characterize LAB strains isolated from traditional kefir 
grains, displaying in vitro properties related to their 
probiotic potential, according the guidelines recom-
mended by FAO/WHO (2006). After a complete char-
acterization and the corresponding in vivo trials, these 
strains could be ultimately included as probiotics in 
functional foods.
MATERIALS AND METHODS
Isolation of Bacteria from Kefir Grains
The LAB were isolated by dilution and plating from 
4 kefir grains collected in different regions of Brazil. 
Briefly, 10 g of each kefir sample was homogenized in 
90 mL of sodium citrate (2%). Serial decimal dilutions 
were obtained and plated on lactobacilli de Man, Rogo-
sa, Sharpe (MRS) and M17 agar media (Difco, Sparks, 
MD) supplemented with 200 μg/mL of cycloheximide 
(Sigma-Aldrich, St. Louis, MO), and incubated in 
aerobic and anaerobic (Gaspak EZ, Difco) conditions at 
30°C for 72 h. Representative colonies of all morpholo-
gies were taken randomly and purified on the same me-
dia by subculturing. Gram-positive, catalase-negative 
isolates were considered as presumptive LAB, which 
were stored in 15% glycerol at −80°C.
For all subsequent assays, LAB were activated in 
the corresponding media at 30°C for 18 to 24 h, and 
subcultured in the same conditions.
Tolerance of the Isolates at Low pH
The ability of the isolates to tolerate low pH was 
assayed as described by Nishida et al. (2008) in MRS 
broth supplemented with 0.2% sodium thioglycolate 
(MRS-THIO). In short, overnight cultures were har-
vested by centrifugation and cells were suspended in 
PBS (pH 6.5) to obtain an optical density at 600 nm 
(OD600) = 0.5. Cell suspensions (≈10
7 to 109 cfu/mL) 
were 10-fold diluted with MRS medium, adjusted to pH 
3.0 with HCl, and incubated at 37°C for 3 h. The pH 
tolerance of the cells was determined by enumerating 
the viable cells on MRS agar plates. Nontreated cul-
tures used as controls were suspended in conventional, 
nonacidified MRS (pH 6.5).
Bile Tolerance of the Isolates
Tolerance to bovine bile (Oxgall, Difco) was assayed 
by growing the isolates in agar plates and broth, fol-
lowing the procedure reported by Delgado et al. (2007) 
and Guo et al. (2009), respectively. The growth rate of 
the strains was estimated in MRS-THIO broth in the 
absence (control) and in the presence (test) of 0.3% 
Oxgall. Overnight cultures were inoculated (1%) into 
the liquid medium, and cultured at 37°C for up to 9 h. 
Absorbance at 620 nm was measured every hour. The 
effect of the bile salts was scored as the time difference 
required to increase by 0.3 units the absorbance of the 
culture at 620 nm (OD620) in MRS-THIO broth with 
and without 0.3% bile salts. The growth delay (hours) 
between the culture media was considered as the lag 
time (LT).
Additionally, tolerance of strains to different con-
centrations of bile salts was assayed by a plate assay. 
Individual colonies growing in MRS agar plates were 
suspended in 2 to 5 mL of sterile saline solution 0.85% 
at a density corresponding to McFarland standard 1. 
Aliquots of the suspensions (10 μL) were spotted onto 
bile-containing 0.3, 0.5, 1, and 2% (wt/vol) agar plates. 
The plates were incubated at 37°C under anaerobic 
conditions and growth was recorded after 24 to 48 h. 
A plate without bile was used as positive control. The 
experiments were performed in duplicate.
Identification of LAB Isolates
Total genomic DNA of the isolates was extracted 
using the GenElute Bacterial Genomic DNA kit 
(Sigma-Aldrich), following the manufacturer’s recom-
mendations. Purified DNA was used as a template to 
amplify a segment of the 16S rRNA gene by the PCR 
technique using the universal prokaryotic primers S-
D-Bact-0008-a-S-20 (27F; 5c-AGAGTTTGATCCTG-
GCTCAG-3c) and S-*-Univ-1492R-b-A-21 (1492R; 
5c-GGTTACCTTGTTACGACTT-3c). For the ampli-
fied ribosomal DNA restriction analysis (ARDRA), 
amplicons were purified through GenElute PCR Clean-
Up columns (Sigma-Aldrich), digested with HaeIII and 
HhaI restriction enzymes (Invitrogen, Paisley, UK) 
and electrophoresed in agarose gels. Gels were stained 
with ethidium bromide (0.5 mg/mL) and photographed 
under UV light. Representative amplicons of the dif-
ferent ARDRA profiles were sequenced. Sequencing 
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was accomplished in an ABI 373 DNA sequencer 
(Applied Biosystems, Carlsbad, CA). On average, 850 
bp of sequence were obtained, which were compared 
with those deposited in the GenBank database using 
the BLAST program (http://www.ncbi.nlm.nih.gov/
BLAST/). Following the criterion applied by Palys et 
al. (1997), sequences with a percentage of identity of 
98% or higher to those in databases were allocated to 
the same species.
Molecular Typing Analyses
To exclude replicates, LAB isolates were grouped 
by both repetitive extragenic palindromic PCR (rep-
PCR), using the primer BOXA2R (5c-ACGTGGTTT-
GAAGAGATTTTCG-3c), as reported by Koeuth et 
al. (1995), and random amplification of polymorphic 
DNA (RAPD) with primer M13 (5c-GAGGGTGGCG-
GTTCT-3c), as reported by Rossetti and Giraffa (2005). 
Banding patterns were examined with the Bionumerics 
6.5 software program (Applied Maths, Sint-Martens-
Latem, Belgium) using Dice’s coefficient. Cluster 
analyses of composite data obtained with rep-PCR and 
RAPD were achieved using the unweighted pair group 
method with arithmetic averages.
Antimicrobial Activity
Pathogen Inhibition. The capability of the 
strains to inhibit a group of foodborne pathogens was 
determined using an agar spot test as described by 
Ripamonti et al. (2011). Overnight test cultures were 
spotted (2 μL) on the surface of modified MRS agar 
(without ammonium citrate and sodium acetate) and 
incubated anaerobically for 24 h at 30°C. Cells were 
then inactivated with chloroform for 30 min. Escherichia 
coli ATCC 25922, Salmonella enterica var. Enteritidis 
ATCC 13076, Staphylococcus aureus ATCC 25923, and 
Listeria monocytogenes ATCC 15313 were used as indi-
cators. A 100-μL volume of an overnight culture of each 
indicator was mixed with 10 mL of brain heart infusion 
(Difco) soft agar (0.7%), and poured onto MRS agar 
plates. These were incubated aerobically at 37°C for 24 
h. Lactobacillus acidophilus ATCC 4356 was used as a 
negative control. Inhibition but no clear-cut halo or a 
halo <1 mm was recorded as ±; a clear zone of growth 
inhibition around spots >1 mm was scored as positive 
(+); and an inhibition zone between 2 and 5 mm sur-
rounding the colony was recorded as ++.
Bacteriocin Production. The production of 
bacteriocin-like inhibitory substances (BLIS) was suc-
cessively examined using an agar spot test and a well-
diffusion assay. Lactobacillus sakei CECT 906 and Lac-
tococcus lactis IL 1403, 2 well-recognized bacteriocin-
susceptible strains (Alegría et al., 2010), and Listeria 
monocytogenes ATCC 15313 were used as indicators. 
Overnight cultures were spotted on the surface of M17 
and MRS agar plates (0.2% glucose), incubated for 24 
h at 30°C for lactococci and leuconostoc strains, and 
at 37°C for lactobacilli, and inactivated as described 
previously with chloroform. Spots were covered with 10 
mL of soft agar (0.75%) inoculated with the indicators 
and incubated under the required conditions.
Positive cultures were tested by a well-diffusion as-
say. Briefly, 20 mL of agar medium at 45°C was vigor-
ously mixed with 200 μL of an overnight culture of each 
indicator and poured into Petri dishes. Supernatants 
from overnight cultures of the test strains were neutral-
ized to pH 6.5 to 7.0 with 0.1 M NaOH, centrifuged 
at 10,000 × g for 5 min at 4°C, and filter-sterilized 
through a 0.20-μm pore membrane (Millipore, Bedford, 
MA). Fifty-microliter aliquots of each supernatant were 
placed in a well excavated in the agar. To allow the 
diffusion of the supernatant into the agar, plates were 
maintained at 4°C for 1 h before incubation. Inhibition 
of the indicators was evaluated after incubation at 37°C 
for 24 h.
To investigate the proteinaceous nature of the BLIS, 
supernatants were tested in the vicinity of wells filled 
with 50 μL of a solution of either proteinase K or 
pronase (each at a concentration of 20 mg/mL). After 
incubation, plates were examined to judge whether the 
inhibitory substance was sensitive to proteolysis. Lac-
tococcus lactis 1A6, a nisin producer strain (Alegría et 
al., 2010), was used as control. Tests were performed in 
duplicate.
Antioxidative Activity
Sample Preparation for the Antioxidative As-
says. Overnight cultures in MRS broth were harvested 
by centrifugation at 4°C for 10 min, washing with 
isotonic saline solution (0.85%) at 4°C, and suspended 
in phosphate buffer with 1 mM EDTA, pH 7.5. The 
suspension was adjusted to an OD600 = 1.0. To obtain 
the cell extracts, cells were disrupted in a cell disrup-
tor (Constant Systems, Daventry, UK) and deposited 
immediately in an ice bath. The extracts were then 
centrifuged at 10,000 × g at 4°C for 10 min to eliminate 
cell debris.
Total Antioxidative Activity. To evaluate the 
total antioxidative activity (TAA) of the strains, the 
linolenic acid (LA) test was used as described by Kul-
lisaar et al. (2002), using 45 μL of the samples (lysate 
or whole bacterial cells). The absorbance at 534 nm 
was measured on a UV-Vis Spectrophotometer (Hitachi 
High-Technologies, Tokyo, Japan) and the percentage 
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of TAA of the samples was expressed as [1 − (As/Ac)] × 
100], where As is the absorbance in the presence of the 
sample and Ac is the absorbance of the control without 
sample. Intact cells and cell lysates were assayed in 
triplicate.
Glutathione Assay. Reduced and oxidized gluta-
thione and the glutathione redox status were evaluated 
using cell-free extracts and the GSH/GSSG Ratio As-
say kit (Millipore, Billerica, MA) following the manu-
facturer’s instructions. The glutathione content was 
quantified on the basis of a standard curve generated 
with known amounts of glutathione. The reduced gluta-
thione (GSH) content was calculated as the difference 
between the total GSH and the oxidized glutathione 
(GSSG). The glutathione redox ratio was expressed as 
GSH/GSSG. Escherichia coli CECT 515 was used as a 
positive control (Masip et al., 2006).
Adhesion Assay
The epithelial intestinal cell line Caco-2 purchased 
from the European Collection of Cell Culture (ECACC 
86010202) was used to assess the adhesion ability of 
selected strains. The culture and maintenance of the 
cell line were carried out following standard procedures 
(Sánchez et al., 2010) using DMEM medium supple-
mented with 20% fetal bovine serum, nonessential ami-
noacid solution, and a mixture of antibiotics (50 μg/
mL of penicillin-streptomycin, 50 μg/mL of gentamicin, 
and 1.25 μg/mL of amphotericin B; all reagents from 
Sigma-Aldrich). The cell line was used after reaching 
the confluent-differentiated monolayer state (13 ± 1 d). 
The strain Lactobacillus rhamnosus LMG 18243 (also 
known as Lb. rhamnosus GG) was used as a reference 
control for adherence.
Lactobacilli strains, grown overnight in 10 mL of 
MRS under standard conditions, were harvested by 
centrifugation, washed twice in Dulbecco’s PBS solu-
tion (Sigma-Aldrich), and suspended in supplemented 
DMEM media without antibiotics, at a concentration 
of approximately 108 cfu/mL. To remove antibiotics 
from the cells, monolayers were washed twice in Dul-
becco’s PBS. Subsequently, the bacterial suspensions 
were added at a bacteria:eukaryotic cell ratio of 10:1, 
and incubated for 1 h at 37°C in a 5% CO2 atmosphere. 
Afterward, wells were gently washed 3 times with 
Dulbecco’s PBS buffer to remove nonadhered bacte-
ria. Monolayers were disrupted with an EDTA-trypsin 
solution (Sigma-Aldrich), and the attached bacteria 
were counted by plating in MRS agar. Adhesion was 
expressed as the percentage of bacteria adhered with 
respect to total number of bacteria added. Experiments 
were carried out using 2 independent Caco-2 plates (2 
consecutive passes), and in each plate bacterial strains 
were analyzed in duplicate.
Safety Assessment
Hemolysin Production. Hemolysin production 
was analyzed on Columbia agar plates containing 5% 
sheep blood (bioMérieux, Montalieu-Vercieu, France). 
The presence of β- or α-hemolysis is indicated by the 
formation of clear or greenish zones around the colo-
nies, respectively.
Antibiotic Resistance. The MIC of a series of 
antibiotics was assayed on the selected strains by mi-
crodilution in VetMIC plates for LAB (SVA, Uppsala, 
Sweden), following the manufacturer’s recommenda-
tions. Colonies grown on LSM (Klare et al., 2005) agar 
plates were suspended in 5 mL of sterile saline solution 
(0.9%) to obtain a density corresponding to McFarland 
standard 1. Suspensions were further diluted 1:1,000 
in LSM. One hundred microliters of this dilution was 
added to each well of the VetMIC plate. The plates 
were incubated at 37°C for 48 h. The MIC were defined 
as the lowest antibiotic concentration at which no vi-
sual growth was observed.
Enzyme Activities. Enzyme activities were mea-
sured by the commercial, semiquantitative API-ZYM 
system (bioMérieux) following the manufacturer’s rec-
ommendations. In short, 65 μL of a cell suspension cor-
responding to McFarland standard 5 were inoculated 
in each well of the API-ZYM strips. Enzyme activities 
were evaluated after 4 h of incubation in anaerobiosis 
at 37°C. Enzyme activities were recorded from 0 (no 
activity) to 5 (≥40 nmol of product released) with the 
API-ZYM color reaction chart.
Statistical Analyses
Statistical comparisons for both the adhesion and 
antioxidative tests were performed using the Statistica 
software package for Windows version 7.0 (Statsoft, 
Tulsa, OK). Significant differences between treatments 
were tested by the ANOVA test (1-way ANOVA), fol-
lowed by a comparison between means using Fisher’s 
least significance difference method, with levels of sig-
nificance set at P < 0.05.
RESULTS
LAB Screening for pH and Bile-Salt Tolerance
Thirty-seven out of the 150 tested LAB isolates 
showed tolerance to pH 3.0 during 3 h of incubation. 
However, the growth in these conditions was not com-
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parable with that in conventional MRS (pH 6.5), with 
reductions in counts at least 2 logarithmic units com-
pared with controls. These 37 isolates were tested by 
a plate assay for resistance to different bile concentra-
tions ranging from 0.3 to 2%, and by tolerance in liquid 
containing 0.3% of Oxgall. In the latter medium, a LT 
ranging from 0.5 to 4 h was observed for 34 isolates 
(Table 1); these were considered to be bile tolerant. In 
contrast, 3 LAB isolates presented an LT >9 h; these 
were considered bile susceptible.
As a result of the bile plate assay, 34 isolates grew in 
0.3%, 25 grew in 0.5%, 13 in 1%, and 8 in 2% (Table 1).
LAB Identification
Among the 34 isolates 4 different representative AR-
DRA profiles were observed with the HaeIII and HhaI 
restriction enzymes (data not shown). Representative 
16S rDNA amplicons of each of the different profiles 
were selected for sequencing. Sequence comparisons 
showed a homology higher than 98% to 4 different 
LAB species. Therefore, the 34 isolates were identified 
as follows: Leuconostoc mesenteroides (18), Lactococcus 
lactis ssp. cremoris (8), Lactobacillus paracasei (5), and 
Lactococcus lactis ssp. lactis (3).
LAB Typing
The LAB isolate typing was performed by a combina-
tion of rep-PCR and RAPD techniques. Using a 90% 
similarity as threshold (Figure 1), 32 different strains (4 
Lb. paracasei, 10 Lc. lactis, and 18 Leu. mesenteroides) 
were considered. These were all subjected to further 
analyses.
Antimicrobial Properties
Antagonistic Activity Against Pathogens. 
Pathogens were inhibited by most strains in the agar 
spot test (Table 2). Listeria monocytogenes, E. coli, and 
Table 1. Bile resistance of 32 identified and typed lactic acid bacteria isolated from kefir grains
Strain Identification Origin1
Bile assay
Lag time (h), 
0.3% bile
Growth plate2
0.3% bile 0.5% bile 1% bile 2% bile
MRS17 Lactococcus lactis ssp. cremoris AR 2 + + + +
M1711B AR 3 + + − −
MRS26 AR 1.5 + + − −
MRS47 AD 3 + − − −
M1732 AR 1 + − − −
M1734 AR 2 + + − −
M171 AR 1 + + − −
MR2 Lc. lactis ssp. lactis AV 1 + + + +
MRS52 AD 1 + + − −
MRN3 AV 4 + + − −
MRN4 Lactobacillus paracasei AR 1 + + + +
MRS59 AF 2 + + + −
M1743 AF 2 + + + +
MRS55 AF 3 + + + −
MRS2 Leuconostoc mesenteroides AR 2 + + − −
GYP8 AR 3 + + + −
MRS12 AR 1.5 + + − −
MRS50 AD 2 + − − −
MRS48 AF 3 + − − −
MRS53 AF 2 + − − −
MRS25 AR 2 + + + +
GYP7 AR 1 + + + +
MRS8 AR 2 + + − −
MRS14 AR 1.5 + + − −
GYP5 AR 2 + − − −
MRS10 AR 4 + + − −
GYP9 AR 1 + + + +
GYP12 AR 0.5 + + + −
M1721 AR 2.5 + − − −
MRS19 AR 1.5 + − − −
MRS24 AR 1 + − − −
M1711A AR 2 + + − −
1Region of Brazil: AR = Niterói, RJ; AD = Lavras, MG; AV = Viçosa, RJ; and AF = Alfenas, MG.
2Growth plate: – = no growth; + = positive growth.
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Figure 1. Combined dendrogram obtained from repetitive extragenic palindromic (rep)-PCR and random amplification of polymorphic DNA 
(RAPD)-PCR profiles, using BOXA2R and M13 primers corresponding to 5 Lactobacillus paracasei strains (panel A), 11 Lactococcus lactis 
strains (panel B), and 18 Leuconostoc mesenteroides strains (panel C).
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S. enterica were inhibited by 23, 22, and 20 strains, 
respectively. In contrast, S. aureus was inhibited by 
only 7 strains. Pathogen inhibition, however, was not 
confirmed by the agar well-diffusion assay, with the ex-
ception of L. monocytogenes, which was inhibited by 4 
strains after neutralization of the cell-free supernatants 
(see below).
Bacteriocin-Like Inhibitory Substance Pro-
duction. Lactobacillus sakei CECT 906 was inhibited 
by 4 strains and Lc. lactis IL 1403 by 12 strains (Table 
2) in the agar spot assay. The isolates demonstrating 
antibacterial activity against any of the indicators 
were subsequently subjected to the well-diffusion as-
say. None of the Leuconostoc strains showed inhibition 
against indicators in this assay. Lactococcus lactis IL 
1403 was inhibited by 3 lactococci strains (MRS26, 
M171, and MRS52). Both L. monocytogenes ATCC 
15313 and Lb. sakei CECT 906 were inhibited by the 
3 above-mentioned lactococci strains and one Lb. pa-
racasei (MRS55) strain. The proteinaceous nature of 
the BLIS produced by these 4 strains was confirmed by 
proteinase treatment of the cell-free supernatants.
Antioxidative Activity
According to Hütt et al. (2006), LAB strains with a 
TAA value >20% are considered to have antioxidative 
activity. Three of the LAB strains from kefir grains (2 
Lb. paracasei; MRS 59 and M1743, and 1 lactococcal 
strain; MRS 52) showed percentages above this value 
in either intact cells or lysate supernatants (Table 3). 
All other strains showed mean TAA values below 15% 
Table 2. Antimicrobial activity data of 32 identified and typed lactic acid bacteria isolated from kefir grains
Strain1 Identification Origin
Inhibition profile spot test2
Pathogen inhibition Bacteriocin production
I II III IV IV V VI
MRS17 Lactococcus lactis ssp. cremoris AR ±  ++  − − − − −
M1711B AR ± ± − − − − −
MRS26 AR ++ − ± ++ ++ ++ ++
MRS47 AD ++ − − − − − −
M1732 AR − ++ − ± ± − −
M1734 AR − ++ − ± ± − ±
M171 AR ++ − ± ++ ++ ++ ++
MR2 Lc. lactis ssp. lactis AV ++ − − ++ ++ − −
MRS52 AD − − − ++ ++ ++ ++
MRN3 AV ++ ± − ++ ++ − −
MRN4 Lactobacillus paracasei AR ± ++ − − − − ++
MRS59 AF ++ ++ − ++ ++ − ++
M1743 AF ++ ++ ± ± ± − ±
MRS55 AF ++ ++ − ++ ++ ++ ++
MRS2 Leuconostoc mesenteroides AR − − − ± ± − ±
GYP8 AR ± ± ± − − − −
MRS12 AR + ± ± ± ± − −
MRS50 AD − − ± ± ± − ±
MRS48 AF − − + ± ± − ±
MRS53 AF − − − − − − −
MRS25 AR ± − − ± ± − ±
GYP7 AR ± − − − − − −
MRS8 AR − ± − ± ± − −
MRS14 AR − ± − ± ± − −
GYP5 AR + ± − ± ± − −
MRS10 AR ± ± − ± ± − −
GYP9 AR ± ± − ± ± − −
GYP12 AR − − − − − − −
M1721 AR ± ± − ± ± − −
MRS19 AR ± ± − ± ± − −
MRS24 AR ± ± − ± ± − −
M1711A AR ± ± − − − − −
1Strains in bold produce bacteriocin-like inhibitory substances.
2Indicators: I = Escherichia coli ATCC 25922; II = Salmonella enterica serovar Enteritidis ATCC 13076; III = Staphylococcus aureus ATCC 
25923; IV = Listeria monocytogenes ATCC 15313; V = Lactobacillus sakei CECT 906; VI = Lactococcus lactis IL1403. Activity: ± = inhibition 
but no clear halo; + = presence of a clear zone of growth inhibition around spots >1 mm; ++ = presence of a clearly defined inhibition zone 
between 2 and 5 mm surrounding the colony in the spot test or the wells containing neutralized, cell-free supernatant; – = no inhibition.
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(data not shown), except for 2 other lactobacilli strains 
(MRS55 and MRN4), which showed a TAA between 15 
and 20% (Table 3).
The 3 LAB strains that showed higher values in 
the TAA test (P < 0.05) were further analyzed by 
the glutathione assay (Table 3). The total gluthatione 
content values found for the LAB strains were lower 
than the positive control (E. coli; P < 0.05). However, 
the calculated glutathione redox ratio (GSSG/GSH), 
used to investigate oxidative stress, was similar for all 
the strains, except for the Lb. paracasei M1743 strain, 
in which the oxidized glutathione (GSSG) content was 
not detectable and, consequently, its GSH/GSSG redox 
ratio could not be calculated.
Based on the results obtained in the antimicrobial 
and antioxidative tests, 3 Lb. paracasei strains (MRS55, 
MRS59, and M1743) were considered as presenting pro-
biotic potential and were selected for further analyses.
Adhesion Capability
The results of the adhesion assay for the 3 selected 
strains are depicted in Figure 2. Adhesion percent-
ages ranged from 0.9 to 9%. The adhesion level of the 
MRS59 strain was similar to that of the reference strain 
GG, whereas those of M1743 and MRS 55 were lower 
(P < 0.05).
Enzymatic Activities and Hemolysin Production
Undesirable activities, such as trypsin, 
α-chymotrypsin, and β-glucuronidase activities, were 
not detected in any of the selected strains. In addition, 
none of the 3 strains showed hemolytic activity under 
the assay conditions.
Antibiotic Resistance
The selected lactobacilli strains were susceptible to 
all the analyzed antimicrobial agents (including tet-
racycline, erythromycin, clindamycin, ampicillin, and 
aminoglycosides) with the exception of vancomycin, for 
which an intrinsic resistance was observed. The chlor-
amphenicol MIC for MRS55 and M1743 strains was 
only one dilution higher (8 μg/mL) than the micro-
biological breakpoint defined by the EFSA (4 μg/mL), 
which is within the normal acceptable variation around 
the means (EFSA, 2012).
Table 3. Data on total antioxidative activity (TAA) and glutathione determinations (total, reduced, and oxidized glutathione and glutathione 
redox ratio) of representative lactic acid bacteria strains from kefir grains showing antioxidative activity1
Strain Identification
TAA test (%) Glutathione test2 (μM)
Intact cells Cell lysate tGSH GSSG GSH GSH/GSSG
MRS52 Lactococcus lactis 
ssp. lactis
20.3 ± 3.5a 11.8 ± 3.9b 0.586 ± 0.23b 0.062 ± 0.03b 0.461 ± 0.14b 8.75 ± 3.19a
MRS59 Lactobacillus 
paracasei
18.4 ± 4.1ac 34.1 ± 9.9a 0.157 ± 0.21b 0.024 ± 0.01b 0.110 ± 0.19b 5.72 ± 3.09a
MRN4 Lb. paracasei 3.5 ± 2.9b 14.7 ± 12.7b ND ND ND ND
M1743 Lb. paracasei 22.3 ± 9.0a 26.0 ± 4.2ab 0.106 ± 0.13b 0 0.106 ± 0.13b 0
MRS55 Lb. paracasei 10.4 ± 2.3bc 18.2 ± 2.1b ND ND ND ND
CECT5153 Escherichia coli ND ND 2.313 ± 0.48a 0.31 ± 0.04a 1.686 ± 0.40a 5.33 ± 0.67a
a–cMeans within columns that do not share a superscript are statistically different according to the least significant differences (LSD) mean 
comparison test (P < 0.05).
1Data are expressed as the means ± SD, based on 3 replicates.
2Glutathione test: tGSH = total glutathione; GSSG = oxidized glutathione; GSH = reduced glutathione; ND = not determined.
3E. coli CECT 515 was used as positive control.
Figure 2. Percentage of adhesion measured as the percentage of 
colony-forming units per milliliter adhered bacteria with respect to col-
ony-forming units per milliliter of added bacteria of the 3 Lactobacillus 
paracasei strains to the intestinal epithelial cell line Caco-2. Columns 
that do not share the same letter are statistically different according 
to the least significant differences (LSD) mean comparison test (P < 
0.05). Lactobacillus rhamnosus GG was used as an adherent reference 
strain.
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DISCUSSION
Beyond their technological function, demand is cur-
rently increasing for new LAB strain probiotic candi-
dates (Ayeni et al., 2011; Argyri et al., 2013). The com-
plex microbiota of kefir, a traditional beverage endowed 
with several health benefits (Leite et al., 2013b), could 
be a source for obtaining novel probiotic strains (Santos 
et al., 2003; Kumura et al., 2004).
In the present study, LAB were isolated from 4 kefir 
grain samples, identified and typed by molecular meth-
ods, and characterized in vitro for recognized probiosis 
properties, such as acidity and bile tolerance and an-
timicrobial and antioxidant activities, key features to 
consider bacterial strains as probiotics. The secretion 
of gastric acid and transit through the stomach con-
stitutes a primary defense mechanism that all ingested 
microorganisms must overcome, including probiotics 
(Gueimonde and Salminen, 2006). The LAB isolates 
from kefir grains were screened and selected for their 
resistance and survival in an acidic environment, as well 
as for their growth in the presence of 0.3% bile salts, 
a similar concentration to that present in the small 
intestine (Vinderola et al., 2008). Though no scientific 
consensus exists on the pH and bile concentration to 
which probiotic strains should be tolerant (Zago et al., 
2011), based on the results, the lactobacilli were able to 
grow in higher bile concentrations (1%). Similar results 
have been previously reported by other authors analyz-
ing LAB strains from different environments (Delgado 
et al., 2007; Vinderola et al., 2008; Zago et al., 2011; 
Ramos et al., 2013).
Molecular typing showed a rather high genetic het-
erogeneity among the LAB isolates from the 4 kefir 
grains as judged by the large number of different pro-
files obtained.
Some of these LAB strains exhibited antimicrobial ac-
tivity against pathogens, and 4 of them produced BLIS, 
which might provide advantage in competing either in 
a food product or in the gut (Servin, 2004; Vinderola 
et al., 2008). Moreover, we observed one Lactococcus 
BLIS-producing strain, as well as 2 Lb. paracasei, that 
showed an antioxidative activity higher than those of 
other tested LAB strains (P < 0.05), indicating they 
may aid in protecting cells from oxidative damage (Lin 
and Chang, 2000; Zhang et al., 2010). In particular, 
the lactococci strain showed higher TAA in intact cells; 
meanwhile, in the Lb. paracasei strain, the antioxida-
tive activity was more relevant in cell extracts indicat-
ing that this activity might be also relevant in case of 
bacterial lysis into the gastrointestinal tract releasing 
of the intracellular content. Furthermore, GSH, an im-
portant component of the cell defense system against 
oxidative stress (Masip et al., 2006), was detected for 
all the LAB strains that showed TAA values >20%. 
However, the obtained values suggest that the antioxi-
dative effect displayed by some of these strains could be 
attained by means of other mechanisms different from 
glutathione protection, such as enzymatic antioxidants. 
The antioxidative activities of LAB strains have been 
under investigation in other studies (Kullisaar et al., 
2002; Li et al., 2012; Chen et al., 2014). This protective 
property may be useful as a defense mechanism in the 
intestinal microbial ecosystem.
Strains belonging to the Lactobacillus genus are 
commonly used as probiotics (FAO/WHO, 2006; Guei-
monde and Salminen, 2006; Zago et al., 2011). Three 
Lb. paracasei strains were considered as appropriate 
probiotic candidates and selected for further charac-
terization of desirable and undesirable probiotic-related 
properties.
The capacity to adhere to the intestinal mucosa is 
an important property for probiotic strains because 
they should, at least transiently, colonize the host gut 
(FAO/WHO, 2006). The human colon adenocarcinoma 
cell line Caco-2 is widely accepted as a model for assess-
ing the adhesion ability of probiotic candidates (Guei-
monde and Salminen, 2006; Ayeni et al., 2011). One Lb. 
paracasei strain in this study (MRS59) showed similar 
adhesion values to the recognized probiotic strain Lb. 
rhamnosus GG, suggesting it may well be a good in 
vivo colonizer.
None of these lactobacilli showed β-glucuronidase 
activity, which may have negative effects in the colon 
and has been considered a carcinogenic enzyme (Mon-
teagudo-Mera et al., 2011). In contrast, all 3 strains 
produced β-galactosidase, a beneficial enzyme consider-
ing both probiotic and technological aspects, support-
ing the reduction of lactose intolerance as well as milk 
acidification (Monteagudo-Mera et al., 2011). These 
strains also presented α-glucosidase and β-glucosidase 
activity, which could contribute to polysaccharide 
digestion (Papamanoli et al., 2003). The presence of 
glycosidase activities in food cultures seems to have 
an effect on sensory properties because flavor is often 
linked to sugar metabolism (Papamanoli et al., 2003; 
Mesas et al., 2011).
In summary, 32 different LAB strains isolated from 
kefir grains showing good survival under normal gastro-
intestinal conditions were evaluated in vitro for antimi-
crobial and antioxidative activities in this study. Among 
the analyzed strains, 3 Lb. paracasei strains were further 
selected. The presence of harmful enzymatic activities 
and atypical antibiotic resistances among the selected 
strains was ruled out. Based on a long history of human 
consumption, Lb. paracasei, like many other LAB spe-
cies, is granted a qualified presumption of safety (QPS) 
status (EFSA, 2011), allowing unrestricted applica-
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tion in food and feed, provided antibiotic resistance 
is absent. Among the 3 selected strains, Lb. paracasei 
MRS59 showed the highest number of in vitro probiosis 
properties; consequently, it was considered as the most 
appropriate kefir-derived candidate to be used as a pro-
biotic. Further in vivo studies should be also performed 
to confirm its potential beneficial effects.
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